3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Melanoma
2
rrCLL
1
Multiple Myeloma
1
Leukemia, Prolymphocytic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
pembrolizumab
1
dinaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
rrCLL
×
dinaciclib
×
Clear all
NCT02684617
2021-03-01
KEYNOTE-155
Merck Sharp & Dohme LLC
Phase 1
Terminated
75 enrolled
17 charts